REFERENCES
1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49.
2. Liu Y, Liu L. Changes in the epidemiology of hepatocellular carcinoma in Asia. Cancers 2022;14:4473.
3. Alliance of Chinese Expert Consensus on Neoadjuvant Therapy for Hepatocellular Carcinoma, Committee of Digestive Surgery of Chinese Research Hospital Association, Committee of Liver Cancer, Chinese Anti-Cancer Association. [Chinese expert consensus on neoadjuvant therapy for hepatocellular carcinoma (2023 edition)]. Zhonghua Wai Ke Za Zhi 2023;61:1035-45.
